Question

Which of the following statements is False with regard to the FDA's view of pharmacy compounding?
I. The FDA views pharmacy compounding as an important part of the overall health care of a patient.
II. The FDA would like to regulate the practice of pharmacy compounding because errors occur.
III. The FDA takes the view that pharmacy compounding does not provide patients with a valuable service.
a. I only
b. II only
c. III only
d. II and III only

Answer 1

d. II and III only

Explanation: The FDA does view pharmacy compounding as an important part of patient care (I is true). It generally does not seek to regulate the practice of pharmacy compounding itself (that is primarily regulated by state boards), though it does regulate drug manufacturing and intervenes when compounding crosses into large-scale manufacturing or raises safety concerns — so statement II is false as written. Statement III is also false because the FDA recognizes compounded medications provide a valuable service.